Fortis Healthcare says no risk of bankruptcy

Fortis Healthcare confirmed a report that the company had availed of a three-year loan of Rs 160 cr, but denied that it was done to avoid bankruptcy. “We wish to confirm that the Company has availed a secured financing facility upto Rs. 160 crore from RattanIndia Finance Private Limited on March 29, 2018.. We would […]

Fortis Healthcare director quits

Fortis Healthcare, which is under the scanner of the Serious Fraud Investigation Office, said one of its independent directors, Joji Gill, stepped down due to ‘personal reasons’. “Ms Joji Sekhon Gill has tendered her resignation from the directorship of the company with effect from March 7 due to personal reasons, primarily attributed to her occupation […]

Lupin launches testosterone solution in the US

Pharma major Lupin said it has launched a testosterone topical solution in the US for males suffering from the deficiency of the hormone. Lupin’s Testosterone Topical Solution is the generic equivalent of Eli Lilly and Company’s Axiron solution, Testosterone Topical Solution, 30 mg per actuation had annual sales of approximately $179 million in the US, […]

Suven gets patents in India, South Korea

Drug maker Suven Life Sciences Ltd said it secured more patents in India and South Korea for its drugs designed for treating neurodegenerative diseases. The India product patent is valid through 2029, while the Korean one is good for up to 2033, the company that focuses on neurological diseases said. “The granted claims of the […]

Lupin gets USFDA nod for scalp solution

Pharma Major Lupin announced that it has received final approval from the US Food & Drug Administration to market a generic version of Dovonex Scalp Solution from Leo Pharmaceutical Products Ltd. Calcipotriene Topical Solution is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. Lupin’s Calcipotriene Topical Solution, 0.005% (Scalp Solution) […]

DENGUE DEATH: Haryana govt probe finds Fortis Hospital guilty

An official inquiry by the Haryana government has found the Gurgaon Fortis hospital guilty of overcharging and several other violations of law, media outlets reported. Quoting the official copy of the report, Mirror Now said that the inquiry committee found the hospital guilty of negligence, lapses, unethical and unlawful acts on the part of the team […]

Boosted by Jio’s success, Mukesh Ambani unveils his future plans

Mukesh Ambani, India’s richest man, said telecom was the first of his big bet, and he will now use his resources to solve problems in three other difficult areas — agriculture, education and healthcare. Speaking at the HT Leadership Summit, Ambani said his primary motivation was not to make money. “Money has never meant much […]

NATCO Pharma to sell multiple sclerosis drug in USA via Mylan

NATCO Pharma Limited said it the US Food and Drug Administration approved the generic drug application filed by its marketing partner Mylan for injections used in the treatment of multiple sclerosis, a chronic inflammatory disease of the central nervous system. The drug, Glatiramer Acetate, will be manufactured by NATCO and sold by Mylan, and are […]

AU Small Finance Bank to distribute Aditya Birla Health insurance

AU Small Finance Bank has tied up with Aditya Birla Health Insurance to to distribute the latter’s health insurance products. The bank will act as a corporate agent, it said. “This tie up shall be mutually beneficial for ABHICL & AU SMALL FINANCE BANK in terms of business, market penetration and reach,” it said. Aditya […]

Glenmark Pharma gets USFDA approval for Desonide skin ointment

Pharma giant Glenmark Pharmaceuticals said it received final approval to sell skin oinment Desonide Lotion in the US. The ointment has annual sales of approximately $23.2 million. The medicine is used to treat eczema, dermatitis, allergies, rashes etc. Desonide reduces the swelling, itching and redness that can occur in these types of conditions. The United […]

Glenmark to launch Desonide topical ointment in US

Glenmark Pharmaceuticals Inc said it has got the go-ahead to launch the generic version of Perrigo’s anti-inflammation ointment Desonide Ointment in the US. Desonide Ointment, 0.05% had annual sales of approximately $23.4 million for the 12 month period ending July 2017, according to IMS Health sales data. Glenmark’s current portfolio consists of 124 products authorized […]

Solar Power is a life saver in Chhattisgarh – Survey

The solar energy revolution may be all about saving the environment, but for the Indian state of Chhattisgarh, it’s impact is more immediate, and life-saving. According to a first-of-its-kind study conducted on primary health centers in the state, PHCs with solar backup admitted 50% more patients and conducted almost twice the number of child deliveries […]

10.6% of Indians have mental disorders; country faces severe shortage

About 10.6% of adults in India suffer from some sort of mental disorder, including substance abuse problems, a study by the National Institute of Mental Health and Neurosciences or NIMHANS found. The study was conducted in 12 states of India by the Bangalore-based institution. Those with mental disorders were classified as those with ‘common mental […]

Zydus Cadila gets USFDA approval for generic version of popular migraine drug

Zydus Cadila said it received final approval from the US Food and Drug Administration to market migraine drug Eletriptan Hydrobromide in the US. The drug is currently marketed and manufactured by Pfizer Inc and sold in the US and Canada under the brand name Relpax. The two key patents covering the drug are listed as […]

Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya

Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya.   Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various […]

Marksans Pharma gets USFDA approval for sale of anti-allergy drug

Marksans Pharma Limited, an Indian pharmaceutical company, said it has received approval from the USFDA for the sale sale of its Loratadine Liquid Filled Capsules 10 mg in the US market. Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body and is used to treat sneezing, runny nose, watery […]

Aurobindo Pharma to launch HIV drug in Africa this year, gets tentative FDA nod

Aurobindo Pharma Limited, a pharmaceutical manufacturing company based in Hyderabad, said it received a tentative approval for HIV drug Dolutegravir from US Food & Drug Administration. It is the first FDA approval of a generic version of Dolutegravir. Through a tie up with ViiV and the Clinton Health Access Initiative, Inc., the product is expected […]

Exit mobile version